Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04644289
Title WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (WoO)
Acronym WoO
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AGO Research GmbH
Age Groups: adult
Covered Countries DEU

No variant requirements are available.